| Value | ₹1.59 Cr |
|---|
BSE filing, NSE: TTFL. Summary written from the filing by ALFA Finder's alert engine.
Trident Texofab Ltd: key numbers
- Share price
- ₹16.00
- Market cap
- ₹23.99 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 114.0×Sector 49.0×
- Promoter holding
- 32.88%+0.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trident Texofab Ltd
All →Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.
Trident Texofab Other Announcement
Trident Texofab Ltd has submitted its quarterly shareholding pattern filing for the period ending September 30, 2026, as per regulatory requirements.
Trident Texofab Management Change
Trident Texofab Limited has appointed M/s. A Bafna & Associates as the new Statutory Auditor for a term of 12 months.
Trident Texofab Board Meeting Outcome
Trident Texofab Ltd's board approved the appointment of a statutory auditor to fill a casual vacancy and convened an EGM for October 28, 2026.
Trident Texofab Annual General Meeting
Trident Texofab held its 18th Annual General Meeting on September 30, 2026. The meeting covered routine items like financial statement adoption and director appointments.
Trident Texofab Promoter Buying: ₹0.01 Cr
Promoter group trust Hardik Desai Family Trust bought 5,412 Trident Texofab shares on BSE. Promoter stake rose from 6.95% to 6.99%.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.04%
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.